FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Que

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Disorders

Co-author Network

Publications

TOP 3
Adrian Zuercher; Michael P Horn; John U Que; Anna Ruedeberg; Martin H Schoeni; Urs B Schaad; Paul Marcus; Alois B Lang
Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
Alois B Lang; Anna Rüdeberg; Martin H Schöni; John U Que; Emil Fürer; Urs B Schaad
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.
J B McClain; Robert Edelman; MJ Shmuklarsky; John U Que; Stanley J Cryz; Alan S Cross
Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusion.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Que (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Adrian Zuercher; Michael P Horn; John U Que; Anna Ruedeberg; Martin H Schoeni; Urs B Schaad; Paul Marcus; Alois B Lang
Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.
FEMS immunology and medical microbiology 2006;47(2):302-8.
2004: Alois B Lang; Anna Rüdeberg; Martin H Schöni; John U Que; Emil Fürer; Urs B Schaad
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection.
The Pediatric infectious disease journal 2004;23(6):504-10.
2001: J B McClain; Robert Edelman; MJ Shmuklarsky; John U Que; Stanley J Cryz; Alan S Cross
Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusion.
Vaccine 2001;19(25-26):3499-508.
2001: Deborah Lehmann; M Kakazo; Gerard Saleu; John Taime; A Javati; Pioto Namuigi; Michael P Alpers; B Wegmüller; M Zellmeyer; Emil Fürer; John U Que; Christian Herzog
Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Papua and New Guinea medical journal 2001;44(1-2):6-16.
2000: Herwig Kollaritsch; Stanley J Cryz; Alois B Lang; Christian Herzog; John U Que; Gerhard Wiedermann
Local and systemic immune responses to combined vibrio cholerae CVD103-HgR and salmonella typhi ty21a live oral vaccines after primary immunization and reimmunization.
Vaccine 2000;18(26):3031-9.
2000: C Panpitpat; U Thisyakorn; Tawee Chotpitayasunondh; Emil Fürer; John U Que; T Hasler; Stanley J Cryz
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Bulletin of the World Health Organization 2000;78(3):364-71.
1999: Alan S Cross; Steven M Opal; Apurba K Bhattacharjee; S T Donta; Peter Peduzzi; Emil Fürer; John U Que; Stanley J Cryz
Immunotherapy of sepsis: flawed concept or faulty implementation?
Vaccine 1999;17 Suppl 2():S13-21.
1999: Jean-François Viret; Didier Favre; B Wegmüller; Christian Herzog; John U Que; Stanley J Cryz; Alois B Lang
Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.
Infection and immunity 1999;67(7):3680-5.
1999: Emily L Richie; Narain H Punjabi; S J Harjanto; F Wangsasaputral; M Sukandar; M Supriatman; Cyrus H Simanjuntak; John U Que; Stanley J Cryz
Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children.
Vaccine 1999;17(11-12):1384-93.
1999: T F Tsai; Herwig Kollaritsch; John U Que; Cecil B Cropp; C Kunz; Gerhard Wiedermann; Christian Herzog; Stanley J Cryz
Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
The Journal of infectious diseases 1999;179(2):522-4.
1997: Pierre Conne; Laurent Gauthey; P Vernet; B Althaus; John U Que; B Finkel; Reinhard Glück; Stanley J Cryz
Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients.
Vaccine 1997;15(15):1675-9.
1997: Herwig Kollaritsch; John U Que; C Kunz; Gerhard Wiedermann; Christian Herzog; Stanley J Cryz
Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine.
The Journal of infectious diseases 1997;175(4):871-5.
1997: Tawee Chotpitayasunondh; C Panpitpat; U Thisyakorn; E Furer; John U Que; T Hasler; Stanley J Cryz
Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
The Southeast Asian journal of tropical medicine and public health 1997;28(1):91-8.
1997: Stanley J Cryz; A Lang; Anna Rüdeberg; J Wedgwood; John U Que; Emil Fürer; Urs B Schaad
Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Behring Institute Mitteilungen 1997;(98):345-9.
1996: Stanley J Cryz; John U Que; Reinhard Glück
A virosome vaccine antigen delivery system does not stimulate an antiphospholipid antibody response in humans.
Vaccine 1996;14(14):1381-3.
1996: Herwig Kollaritsch; E Furer; Christian Herzog; Gerhard Wiedermann; John U Que; Stanley J Cryz
Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.
Infection and immunity 1996;64(4):1454-7.
1995: A B Lang; U B Schaad; A Rüdeberg; J Wedgwood; John U Que; Emil Fürer; Stanley J Cryz
Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
The Journal of pediatrics 1995;127(5):711-7.
1995: Stanley J Cryz; John U Que; Myron M Levine; Gerhard Wiedermann; Herwig Kollaritsch
Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
Infection and immunity 1995;63(4):1336-9.
1995: Arye Rubinstein; Harris Goldstein; M Pettoello-Mantovani; Y Mizrachi; Barry R Bloom; E Furer; B Althaus; John U Que; T Hasler; Stanley J Cryz
Safety and immunogenicity of a V3 loop synthetic peptide conjugated to purified protein derivative in HIV-seronegative volunteers.
AIDS (London, England) 1995;9(3):243-51.
1995: Stanley J Cryz; Harris Goldstein; M Pettoello-Mantovani; A Kim; Emil Fürer; John U Que; T Hasler; Arye Rubinstein
Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine.
Vaccine 1995;13(1):67-71.
1994: Robert Edelman; David N Taylor; Steven Wasserman; J B McClain; Alan S Cross; J C Sadoff; John U Que; Stanley J Cryz
Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously.
Vaccine 1994;12(14):1288-94.
1994: Alan S Cross; A Artenstein; John U Que; T Fredeking; E Furer; J C Sadoff; Stanley J Cryz
Safety and immunogenicity of a polyvalent Escherichia coli vaccine in human volunteers.
The Journal of infectious diseases 1994;170(4):834-40.
1994: Reinhard Glück; R Mischler; B Finkel; John U Que; B Scarpa; Stanley J Cryz
Immunogenicity of new virosome influenza vaccine in elderly people.
Lancet 1994;344(8916):160-3.
1994: Stanley J Cryz; J Wedgwood; A B Lang; A Ruedeberg; John U Que; Emil Fürer; U B Schaad
Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa.
The Journal of infectious diseases 1994;169(5):1159-62.
1993: Stanley J Cryz; Harris Goldstein; Emil Fürer; John U Que; T Hasler; B Althaus; Arye Rubinstein
Prospects for prevention of vertical transmission of human immunodeficiency virus by immunization.
Annals of the New York Academy of Sciences 1993;693():194-201.
1992: U Bruderer; Stanley J Cryz; U B Schaad; M Deusinger; John U Que; A B Lang
Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
The Journal of infectious diseases 1992;166(2):344-9.
1991: U B Schaad; A B Lang; J Wedgwood; A Ruedeberg; John U Que; Emil Fürer; Stanley J Cryz
Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis.
Lancet 1991;338(8777):1236-7.
1991: Stanley J Cryz; Emil Fürer; J C Sadoff; T Fredeking; John U Que; Alan S Cross
Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
The Journal of infectious diseases 1991;163(5):1055-61.
1991: Stanley J Cryz; Alan S Cross; J C Sadoff; A Wegmann; John U Que; Emil Fürer
Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humans.
The Journal of infectious diseases 1991;163(5):1040-5.
1991: Stanley J Cryz; Emil Fürer; John U Que
Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine.
Infection and immunity 1991;59(1):45-50.
1991: Stanley J Cryz; Emil Fürer; John U Que; J C Sadoff; M Brenner; U B Schaad
Clinical evaluation of an octavalent Pseudomonas aeruginosa conjugate vaccine in plasma donors and in bone marrow transplant and cystic fibrosis patients.
Antibiotics and chemotherapy 1991;44():157-62.
1990: David J Gottlieb; Stanley J Cryz; E Furer; John U Que; H Grant Prentice; A S Duncombe; M K Brenner
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients.
Blood 1990;76(12):2470-5.
1990: Stanley J Cryz; Tyrone L Pitt; B Ayling-Smith; John U Que
Immunological cross-reactivity between Enterobacter aerogenes and Klebsiella capsular polysaccharides.
Microbial pathogenesis 1990;9(2):127-30.
1989: Stanley J Cryz; Emil Fürer; T Fredeking; Alan S Cross; J C Sadoff; John U Que
Effect of race and blood group on the immune response to bacterial polysaccharide and conjugate vaccines.
Lancet 1989;2(8678-8679):1533-4.
1989: Stanley J Cryz; J C Sadoff; John U Que
Conjugate vaccines against Pseudomonas aeruginosa and malaria.
Contributions to microbiology and immunology 1989;10():166-89.
1988: Stanley J Cryz; Alan S Cross; G C Sadoff; John U Que
Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
European journal of immunology 1988;18(12):2073-5.
1988: John U Que; Stanley J Cryz; R Ballou; Emil Fürer; M Gross; James F Young; Gail Folena-Wasserman; L A Loomis; J C Sadoff
Effect of carrier selection on immunogenicity of protein conjugate vaccines against Plasmodium falciparum circumsporozoites.
Infection and immunity 1988;56(10):2645-9.